Cite
HARVARD Citation
Su, X. et al. (2021). Sulforaphane prevents angiotensin II‐induced cardiomyopathy by activation of Nrf2 through epigenetic modification. Journal of cellular and molecular medicine. 25 (9), pp. 4408-4419. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Su, X. et al. (2021). Sulforaphane prevents angiotensin II‐induced cardiomyopathy by activation of Nrf2 through epigenetic modification. Journal of cellular and molecular medicine. 25 (9), pp. 4408-4419. [Online].